New blood test diagnoses Alzheimer's disease

Digest more
New blood test diagnoses Alzheimer’s disease and measures how far it's progressed
A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another condition is causing a person’s cognitive symptoms.
An Alzheimer’s Blood Test Might Predict Advanced Disease
With two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind. Earlier diagnosis would mean that people could take advantage of the drugs sooner,
A new blood test could improve how Alzheimer’s disease is diagnosed
The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring cognitive decline effectively.

dementia, Shingles and Alzheimer's disease

Digest more
Shingles is awful, but there may be another reason to get vaccinated. It may fight dementia
Shingrix is a onetime vaccination, given in two doses a few months apart. The CDC recommends it starting at age 50 for most people but also for younger adults with certain immune-weakening conditions – including those who years ago got that first-generation shingles vaccine. Fewer than 40% of eligible Americans have gotten vaccinated.
Shingles Vaccination May Help Protect People from Alzheimer’s Disease
The findings suggest that the shingles virus might play a role in causing at least a subset of dementia cases, Geldsetzer says, and the vaccine may protect against that. Alternatively, it could be that certain vaccines, such as the one for shingles, lead to a broader immune system activation that lowers the risk of dementia developing.
Low 'bad' cholesterol might protect against dementia, Alzheimer's disease
Lower levels of "bad" LDL cholesterol could mean a lower risk of dementia and Alzheimer's disease, a new study says.
Biogen’s tau targeting Alzheimer’s disease therapy gets FDA Fast Track status
Biogen (NASDAQ:BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...
News Medical on MSN32m
Study identifies 17 modifiable risk factors shared between stroke, dementia, and depression
Age-related brain diseases such as stroke, dementia, and late-life depression are a debilitating part of growing older, but people can lower their risk of these diseases through behavioral and ...
NOLA.com6d
Explaining Alzheimer's to a child could be ongoing process. Allow open talks about disease
The explanation of Alzheimer's, given the span of the disease, could become more of an ongoing process for the child rather ...
Alzheimer’s disease study: Boston researchers create at-home smell test for early detection
Albers and colleagues are interested in whether olfactory dysfunction — the sometimes-subtle loss of sense of smell — can ...
How VR technology is changing the game for Alzheimer's disease
Most people donning virtual reality (VR) goggles are seeking the thrill of being immersed in a fictitious video game world.
Clinical Advisor12h
Tau-Targeting Antisense Therapy for Alzheimer Disease Gets Fast Track Status
BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.
Explore more
News-Medical.Net on MSN1d
New drug shows neuroprotective and anti-inflammatory effects in murine models of Alzheimer's
Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited ...
TAG24 on MSN1d
Tackling bad cholesterol levels with statins may reduce dementia risk
Statins are commonly prescribed to help cut the chance of heart attack and stroke. Now new research suggests they may have more benefits.Experts found that people who have low levels of "bad" ...